MYC and cancer: In other cancers, c-myc is not structurally altered, although it is frequently over-expressed due to oncogenic activation of upstream signaling pathways (e.g. Ras, Wnt, Notch), and contributes to their growth- and tumor-promoting potential [3]–[5].